CLINICAL_TRIALS
trial_result
· 2025-09-19
Clinical Trial Update: LUMINOS-102: Lerapolturev With or Without Immune Checkpoint Blockade in Advanced PD-1 Refractory Melanoma [Phase 2]
Summary
Phase 2 clinical trial update (LUMINOS-102) evaluating lerapolturev with or without immune checkpoint blockade in advanced PD-1 refractory melanoma. Results for…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Istari Oncology, Inc. | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2025-09-19